Voyager Therapeutics, Inc. VYGR
Set alert
1.78 USD +0.06 +3.49%
At close · Nov 2
1.78 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
1.71 Day range 1.80
1.68 52-week range 5.48
- YTD
- -54.71%
- 1 year
- -61.88%
- Open
- 1.74
- Prev close
- 1.72
- Mkt cap
- 109.68M
- Vol
- 1.19M
- Avg vol
- 661.94K
- EPS
- -1.81
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.71
- High
- 1.80
- Forward P/E
- -3.41
- Beta
- 0.89
- Short ratio
- 4.44
- Inst. own
- 65.52%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.52
- 200-d avg
- 7.56
- 1y target
- 17.10
Ownership
Held by insiders 16.98%
Held by institutions 65.52%
Float held by institutions 78.92%
Institutions 180
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.94% | 5,430,430 | 31.12M | Sep 29, 2024 |
| Armistice Capital, LLC | 9.52% | 5,200,000 | 29.80M | Sep 29, 2024 |
| EcoR1 Capital, LLC | 7.17% | 3,917,546 | 22.45M | Sep 29, 2024 |
| Vanguard Group Inc | 5.83% | 3,186,427 | 18.26M | Sep 29, 2024 |
| Farallon Capital Management LLC | 4.20% | 2,292,000 | 13.13M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 2.02% | 1,105,044 | 6.33M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.14% | 1,713,895 | 9.82M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.21% | 1,206,285 | 6.91M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.18% | 646,396 | 3.70M | Sep 29, 2024 |
| Price (T.Rowe) Health Sciences Fund | 1.14% | 622,401 | 3.57M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.86% | 469,640 | 2.69M | Aug 30, 2024 |
| Vanguard Explorer Fund, Inc. | 0.84% | 457,063 | 2.62M | Jul 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CARTER TODD ALFRED | Officer | Sale | Feb 20, 2024 | 87,627 |
| FAHEY SANDELL JACQUELYN | Officer | Sale | Oct 1, 2024 | 86,001 |
| FERGUSON TOBY | Officer | Stock Award(Grant) | Mar 31, 2024 | 105,000 |
| HESSLEIN ROBERT W | General Counsel | Sale | Mar 19, 2023 | 102,200 |
| JORGENSEN NATHAN D. | Chief Financial Officer | Stock Award(Grant) | Sep 30, 2024 | 80,000 |
| NEUROCRINE BIOSCIENCE INC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 22, 2023 | 8,575,320 |
Held by funds
66 US ETFs and mutual funds hold VYGR · largest positions